29Apr 2022
Outcomes and Trends of Treatments in High-Risk Differentiated Thyroid Cancer

Outcomes and Trends of Treatments in High-Risk Differentiated Thyroid Cancer

To analyze the variant-specific survival benefits and usage patterns of standardized treatment combinations of surgery (S), radioactive iodine ablation (RAI), and thyroid-stimulating hormone suppression therapy (THST) for high-risk differentiated thyroid cance. Of 21,076 cases, 18,214 underwent survival analysis with a mean ± SD age of 50.6 ± 17.1 years (71.3% female). Furthermore, high-risk differentiated thyroid cancer exhibited varying susceptibilities to different treatment combinations depending on the histology, with the most significant responses to regimens that included RAI. As a result, physician practices have trended toward decreased RAI and increased THST usage.

  • #ent

Like

Save

Share